PGR and breast cancer: Similar to this, basal-like and luminal BC subtypes have been shown to present molecular signatures of differentially expressed miRNAs [24,25] that can be used to categorize the statuses of the estrogen receptor (ER), progesterone receptor (PR), and HER2/neu receptor [26,27,28].